These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23477340)

  • 21. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase.
    You BR; Park WH
    Toxicol In Vitro; 2010 Aug; 24(5):1356-62. PubMed ID: 20417267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG‑63 through the ROS/JNK signaling pathway.
    Tu P; Huang Q; Ou Y; Du X; Li K; Tao Y; Yin H
    Oncol Rep; 2016 Jun; 35(6):3209-15. PubMed ID: 27035222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piperlongumine derivative, CG-06, inhibits STAT3 activity by direct binding to STAT3 and regulating the reactive oxygen species in DU145 prostate carcinoma cells.
    Kim YH; Yoon YJ; Lee YJ; Kim CH; Lee S; Choung DH; Han DC; Kwon BM
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2566-2572. PubMed ID: 29807795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway.
    Chowdhury AA; Chaudhuri J; Biswas N; Manna A; Chatterjee S; Mahato SK; Chaudhuri U; Jaisankar P; Bandyopadhyay S
    PLoS One; 2013; 8(9):e73672. PubMed ID: 24040019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
    León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
    Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective Killing of Cancer Cells Through ROS-Mediated Mechanisms by AMRI-59 Targeting Peroxiredoxin I.
    Yang YJ; Baek JY; Goo J; Shin Y; Park JK; Jang JY; Wang SB; Jeong W; Lee HJ; Um HD; Lee SK; Choi Y; Rhee SG; Chang TS
    Antioxid Redox Signal; 2016 Mar; 24(8):453-69. PubMed ID: 26528922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
    Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
    Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
    Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triggering apoptosis in cancer cells with an analogue of cribrostatin 6 that elevates intracellular ROS.
    Asby DJ; Radigois MG; Wilson DC; Cuda F; Chai CL; Chen A; Bienemann AS; Light ME; Harrowven DC; Tavassoli A
    Org Biomol Chem; 2016 Oct; 14(39):9322-9330. PubMed ID: 27722456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species.
    Goto H; Takahashi H; Fujii H; Ikuta K; Yokota S
    Int J Hematol; 2003 Oct; 78(3):219-25. PubMed ID: 14604280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents.
    Wu Y; Min X; Zhuang C; Li J; Yu Z; Dong G; Yao J; Wang S; Liu Y; Wu S; Zhu S; Sheng C; Wei Y; Zhang H; Zhang W; Miao Z
    Eur J Med Chem; 2014 Jul; 82():545-51. PubMed ID: 24937186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PKCδ sensitizes neuroblastoma cells to L-buthionine-sulfoximine and etoposide inducing reactive oxygen species overproduction and DNA damage.
    Marengo B; De Ciucis C; Ricciarelli R; Passalacqua M; Nitti M; Zingg JM; Marinari UM; Pronzato MA; Domenicotti C
    PLoS One; 2011 Feb; 6(2):e14661. PubMed ID: 21326872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.
    Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P
    Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperlongumine and immune cytokine TRAIL synergize to promote tumor death.
    Li J; Sharkey CC; King MR
    Sci Rep; 2015 May; 5():9987. PubMed ID: 25984950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EF24 induces ferroptosis in osteosarcoma cells through HMOX1.
    Lin H; Chen X; Zhang C; Yang T; Deng Z; Song Y; Huang L; Li F; Li Q; Lin S; Jin D
    Biomed Pharmacother; 2021 Apr; 136():111202. PubMed ID: 33453607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
    Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
    Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
    Ong PS; Chan SY; Ho PC
    Int J Oncol; 2011 Jun; 38(6):1731-9. PubMed ID: 21455570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development.
    Senese S; Lo YC; Huang D; Zangle TA; Gholkar AA; Robert L; Homet B; Ribas A; Summers MK; Teitell MA; Damoiseaux R; Torres JZ
    Cell Death Dis; 2014 Oct; 5(10):e1462. PubMed ID: 25321469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells.
    Golovine KV; Makhov PB; Teper E; Kutikov A; Canter D; Uzzo RG; Kolenko VM
    Prostate; 2013 Jan; 73(1):23-30. PubMed ID: 22592999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological modulation of reactive oxygen species in cancer treatment.
    Ribas J; Mattiolo P; Boix J
    Curr Drug Targets; 2015; 16(1):31-7. PubMed ID: 25395102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.